2025: Kimia Farma (KAEF) Losses Shrink to Rp 334.9 Billion
PT Kimia Farma (Persero) Tbk. (KAEF) recorded a loss attributable to parent company owners throughout 2025 that shrank to Rp 334.9 billion. This loss decreased significantly compared to 2024, which stood at Rp 842.2 billion.
Quoting its financial report submitted in a disclosure to the Indonesia Stock Exchange (BEI), KAEF’s net sales throughout 2025 decreased from Rp 9.9 trillion to Rp 9.2 trillion.
The cost of goods sold also shrank from Rp 6.9 trillion to Rp 6.1 trillion. As a result, KAEF’s gross profit increased to Rp 3.06 trillion from Rp 2.9 trillion in 2024.
In addition to operating expenses decreasing to Rp 3.3 trillion, KAEF also obtained an increase in other income from Rp 35.7 billion to Rp 170.7 billion. Minus foreign exchange differences that rose to Rp 2.3 billion, KAEF’s operating loss throughout 2025 decreased substantially from Rp 810.7 billion to Rp 79.7 billion.
Furthermore, in addition to financial expenses dropping to Rp 590.1 billion, KAEF’s financial income rose to Rp 231.8 billion. Thus, KAEF’s pre-tax loss decreased from Rp 1.2 trillion to Rp 438 billion.
After deducting taxes, KAEF’s net loss for the year throughout 2025 shrank from Rp 1.2 trillion to Rp 443.3 billion.
Meanwhile, total assets throughout 2025 decreased to Rp 14.1 trillion from 2024 assets of Rp 14.9 trillion.
Source: jawawa.id (https://jawawa.id/newsitem/2025-kimia-farma-kaef-losses-shrink-to-rp-334-9-billion-1775631152)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/market/20260406140800-17-724197/2025-rugi-kimia-farma--kaef--susut-ke-rp-3349-miliar), translated from Indonesian